Svetlana Mojsov's Biography

Svetlana Mojsov is a renowned Serbian-American biochemist best known for her pioneering work in the discovery of the GLP-1 hormone, a breakthrough that has transformed diabetes treatment worldwide. Born on June 5, 1948, Mojsov pursued her academic training in chemistry at the University of Belgrade, where she earned her Ph.D. before moving to the United States to further her research. Her career-defining moment came in the 1980s while at Rockefeller University, where she played a pivotal role in identifying the significance of glucagon-like peptide-1 (GLP-1) in regulating blood sugar levels. Despite early controversies regarding the recognition of her contributions, Mojsov's research has been fundamental in the development of modern diabetes medications, profoundly impacting millions of lives globally. Over her long career, Mojsov has received numerous scientific accolades, including the prestigious Warren Alpert Foundation Prize, and her work continues to inspire the next generation of scientists. She is also passionate about classical music, hiking, and painting, sometimes showcasing her artwork in local exhibitions. Mojsov is dedicated to mentoring young scientists and remains active in the field of biotechnology research. Her influence extends beyond the laboratory, as she advocates for greater acknowledgment of women in science. As of 2024, her estimated net worth is $600,000, largely from academic research and patents. Svetlana Mojsov's legacy is defined by her scientific rigor, perseverance, and lasting impact on medical research.